Diseases, Conditions, Syndromes

SARS-CoV-2 protein caught severing critical immunity pathway

Over the past two years, scientists have studied the SARS-CoV-2 virus in great detail, laying the foundation for developing COVID-19 vaccines and antiviral treatments. Now, for the first time, scientists at the Department ...

Medical research

Study finds repurposed drug inhibits enzyme related to COVID-19

With the end of the pandemic seemingly nowhere in sight, scientists are still very focused on finding new or alternative drugs to treat and stop the spread of COVID-19. In a first-of-its-kind study, researchers at the University ...

Medical research

An experimental peptide could block COVID-19

In hopes of developing a possible treatment for COVID-19, a team of MIT chemists has designed a drug candidate that they believe may block coronaviruses' ability to enter human cells. The potential drug is a short protein ...

Genetics

Crowdsourced supercomputing project sets sights on coronavirus

People around the world are isolating themselves to help slow the spread of COVID-19. But there is another way those confined to their homes—but connected online—can join the fight against the novel coronavirus. Among ...

Oncology & Cancer

New computational tool may speed drug discovery

A new computational tool called fABMACS is helping scientists see beyond static images of proteins to more efficiently understand how these molecules function, which could ultimately speed up the drug discovery process.

page 1 from 2